Transitioning from SBIR Phase I to Phase II in 2026
Securing an SBIR Phase I award is a genuine achievement, but most founders quickly discover that it marks the beginning of a longer, more demanding journey rather than the finish line. The leap from Phase I to Phase II is where many promising companies stumble — not because their science is weak, but because they underestimate how different the two phases really are.
Phase I is about demonstrating technical feasibility. Phase II is about proving that your innovation can become a real, commercially viable product or service. That distinction shapes everything from how you write your proposal to how you structure your team and manage your budget over the next two years.
Understanding What Agencies Actually Want in Phase II
Each federal agency that runs SBIR programs — including NIH, NSF, DoD, DOE, and NASA — has its own priorities, review criteria, and expectations for Phase II applicants. What they share in common is a demand for evidence: evidence that Phase I worked, evidence that a market exists, and evidence that your team can execute at a larger scale.
Reviewers in 2026 are paying closer attention to commercialization potential than they did even five years ago. The SBIR program has always carried a mandate to translate federally funded research into economic impact, and agencies are now more rigorous about holding applicants to that standard. A technically brilliant proposal that lacks a credible path to market will score well below a more modest innovation paired with a sharp commercial strategy.
Before you write a single word of your Phase II application, study your agency's current funding priorities. Read recent awards in your technology area. Understand what problems the agency is trying to solve right now, in 2026, not two years ago. If your Phase I results can be framed as a direct answer to those current priorities, your proposal will resonate at a deeper level.
Building on Your Phase I Results Without Overstating Them
Your Phase I final report and the data it contains are the foundation of your Phase II application. Reviewers will look at what you said you would do, what you actually accomplished, and whether your proposed Phase II work flows logically from those results.
Honesty is more strategic than it sounds. Reviewers have seen thousands of applications, and they can identify when results are being stretched to fit a narrative. If your Phase I produced mixed data, explain what you learned and how that knowledge shaped your Phase II approach. A well-reasoned pivot based on real findings is often more persuasive than a perfectly smooth story.
That said, do not undersell genuine progress. Document your results in specific, quantifiable terms wherever possible. If you demonstrated a 40 percent improvement in efficiency under controlled conditions, say so precisely and explain what that means for your target application. Specificity builds credibility.
Crafting a Commercialization Plan That Actually Holds Up
The commercialization plan is the section that separates strong Phase II applications from exceptional ones. This is not a section to delegate to the final week before submission.
A credible commercialization plan in 2026 needs to address several areas with genuine depth:
- Market sizing that goes beyond TAM/SAM/SOM slides and explains why your specific segment is addressable right now
- Customer discovery evidence, such as letters of intent, pilot agreements, or documented conversations with potential buyers
- A clear description of your regulatory pathway if your innovation operates in a regulated space like healthcare, food systems, or aerospace
- Your intellectual property strategy, including any patents filed or pending from Phase I work
- A realistic timeline from Phase II completion to first commercial sale or licensing agreement
Managing the Financial and Operational Realities of Phase II
Phase II awards are substantially larger than Phase I — often ranging from $750,000 to $2 million over two years — and that scale introduces operational complexity that catches many small teams off guard.
Budgeting for Phase II requires a more sophisticated approach than most founders used in Phase I. You will need to account for indirect costs, fringe rates, and subcontractor oversight in a way that holds up to agency scrutiny. If your organization does not already have a negotiated indirect cost rate agreement with the federal government, pursuing one before you submit can strengthen your application and give you more flexibility in how you structure your budget.
On the personnel side, Phase II often requires bringing on additional technical staff or consultants. Think carefully about whether to hire full-time employees or use subcontractors for specific tasks. Each approach carries different cost implications and different risks in terms of your ability to deliver on your technical milestones.
Plan your milestone structure with enough specificity that both you and your program officer will know exactly what success looks like at each stage. Vague milestones create ambiguity that can complicate your relationship with the agency throughout the award period.
Timing, Submission Windows, and What to Do If You Miss the First Cycle
Most agencies operate on defined submission windows for Phase II applications, though the exact timing varies considerably. In 2026, several major agencies including NIH and NSF have continued to offer multiple solicitation cycles per year, which gives applicants some flexibility if they need more time to strengthen their proposal or gather additional data.
The general guidance is to apply for Phase II as close to the completion of your Phase I work as your agency allows. Waiting too long after Phase I ends can raise questions about whether your results are current and whether you have maintained momentum. At the same time, submitting before you have compelling results is a common and costly mistake.
If you receive reviewer feedback from an unsuccessful Phase II submission, treat it as a resource. Many applicants who are not funded on their first attempt are funded on a resubmission after addressing reviewer concerns. The agencies generally want to fund strong work — understanding exactly why a proposal fell short is the most direct path to improvement.
Let FundFly Help You Find and Apply for Your Next Opportunity
Navigating the SBIR ecosystem is time-consuming, and the stakes at Phase II are high enough that having the right information at the right time can make a real difference. FundFly uses AI to match your organization's profile, research focus, and commercialization stage to the funding opportunities most relevant to you — across SBIR and STTR programs, federal agencies, foundations, and beyond.
With access to over one million live funding opportunities, FundFly surfaces the solicitations and deadlines that matter to your work, so you spend less time searching and more time building. Whether you are preparing your first Phase II proposal or managing a portfolio of federal awards, FundFly can help you stay ahead of the cycle.
Create your profile today and see which opportunities are currently matched to your organization.